Ewing's Sarcoma and Second Malignancies
- PMID: 20981341
- PMCID: PMC2957850
- DOI: 10.1155/2011/736841
Ewing's Sarcoma and Second Malignancies
Abstract
Ewing's sarcoma (ES) is a rare tumor that is most common in children and young adults. Late effects of ES therapy include second cancers, a tragic outcome for survivors of such a young age. This paper will explore the frequencies and types of malignancies that occur after ES. Additionally, it will review how second malignancies have changed with the shift in treatment from high-dose radiation to chemotherapy regimens including alkylators and epipodophyllotoxins. The risk of additional cancers in ES survivors will also be compared to survivors of other childhood cancers. Finally, the possible genetic contribution to ES and second malignancies will be discussed.
References
-
- Phillips RF, Higinbotham NL. The curability of Ewing’s endothelioma of bone in children. The Journal of Pediatrics. 1967;70(3):391–397. - PubMed
-
- Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. New England Journal of Medicine. 2003;348(8):694–701. - PubMed
-
- Mike V, Meadows AT, D’Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet. 1982;2(8311):1326–1331. - PubMed
-
- Tucker MA, D’Angio GJ, Boice JD, Jr., et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. New England Journal of Medicine. 1987;317(10):588–593. - PubMed
-
- Strong LC, Herson J, Osborne BM, Sutow WW. Risk of radiation related subsequent malignant tumors in survivors of Ewing’s sarcoma. Journal of the National Cancer Institute. 1979;62(6):1401–1406. - PubMed
LinkOut - more resources
Full Text Sources
